Cargando…
A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes
Background: Although Chemoradiation (CRT) is the curative treatment for SCCAC, many patients present primary resistance. Since it is a rare tumor, response predictors remain unknown. Methods: We performed a prospective cohort study to evaluate biomarkers associated with CRT response, progression-fre...
Autores principales: | Moniz, Camila Motta Venchiarutti, Riechelmann, Rachel Pimenta, Oliveira, Suilane Coelho Ribeiro, Bariani, Giovanni Mendonça, Rivelli, Thomas Giollo, Ortega, Cintia, Pereira, Allan Andresson Lima, Meireles, Sibele Inácio, Franco, Rejane, Chen, Andre, Bonadio, Renata Colombo, Nahas, Caio, Sabbaga, Jorge, Coudry, Renata Almeida, Braghiroli, Maria Ignez, Hoff, Paulo Marcelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558650/ https://www.ncbi.nlm.nih.gov/pubmed/34729104 http://dx.doi.org/10.7150/jca.57678 |
Ejemplares similares
-
Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?
por: Fernandes, Gustavo S., et al.
Publicado: (2017) -
Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
por: Marta, Guilherme Nader, et al.
Publicado: (2021) -
Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis
por: Souza, Karla T, et al.
Publicado: (2016) -
Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies
por: Mathias-Machado, Maria Cecília, et al.
Publicado: (2022) -
Combination of Irinotecan and a Platinum Agent for Poorly Differentiated Neuroendocrine Carcinomas
por: Ramella Munhoz, Rodrigo, et al.
Publicado: (2013)